KATHERINE REHBERG: Open Payments
NPI 1962728303 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 52 payments from 17 companies in 2025. Trend: 2023 $3,031 · 2024 $405 · 2025 $1,314
Food & beverage: $1,202Education: $112
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $192 |
| ABBVIE INC. | 10 | $178 |
| Botanix SB Inc | 2 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $145 |
| Janssen Biotech, Inc. | 3 | $138 |
| GENZYME CORPORATION | 3 | $101 |
| UCB, Inc. | 3 | $89 |
| Galderma Laboratories, L.P. | 4 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $60 |
| Amgen Inc. | 2 | $37 |
Products named: DUPIXENT, SOFDRA, TREMFYA, COSENTYX, RINVOQ, Bimzelx, NEMLUVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
